Premium
This is an archive article published on June 28, 2021

Hope to resolve issues faced by Indians vaccinated with Covishield travelling to EU soon: Adar Poonawalla

Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

Serum Institute CEO Adar Poonawalla. (File)Serum Institute CEO Adar Poonawalla. (File)

Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon.

Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet.

Story continues below this ad

As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).

The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson).

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Loading Taboola...
Advertisement